Novo Nordisk Will Eat Itself In Obesity

 
• By Alexandra Shimmings

The Danish diabetes specialist is forging ahead with pivotal trials for its latest GLP-1 offering semaglutide in obesity after highly impressive Phase II efficacy data, but is likely to take the biggest market share from its own product, Saxenda.

Cannibalism in the nature. Edible frog (Pelophylax kl. esculentus) eats smaller frog
A Frog Eat Frog World • Source: Shutterstock

More from Business

More from Scrip